Related Experiment Video
Updated: Jul 1, 2025
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
962
Ferroptosis-Related Genes Are Associated with Radioresistance and Immune Suppression in Head and Neck Cancer
Ping Huang1,2, Xuejian Ning2, Min Kang1
1Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Genetic Testing and Molecular Biomarkers
|March 13, 2024
Summary
Ferroptosis-related genes, including COL4A1, show promise as diagnostic and prognostic markers for head and neck cancer (HNC). These genes may also serve as therapeutic targets for improving HNC radiosensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Ferroptosis, a form of regulated cell death, is implicated in tumor development.
- The role of ferroptosis in radioresistant head and neck cancer (HNC) is not well understood.
Purpose of the Study:
- To identify ferroptosis-related genes associated with HNC radiosensitivity using bioinformatics and in vitro methods.
- To evaluate the diagnostic and prognostic potential of these genes in HNC.
Main Methods:
- Utilized bioinformatics analysis of public datasets (GSE9714, GSE90761, TCGA) to identify differentially expressed ferroptosis-related genes.
- Performed protein-protein interaction analysis, ROC curve analysis, and Kaplan-Meier survival analysis.
- Conducted in vitro experiments (CCK-8, Transwell, flow cytometry) to investigate the function of COL4A1 in HNC cells.
Main Results:
- Identified hub genes MMP10, MMP1, COL4A1, IFI27, and INHBA with diagnostic potential for HNC.
- These genes were negatively correlated with overall and disease-free survival in the TCGA dataset.
- COL4A1 knockdown inhibited proliferation, migration, and invasion while promoting apoptosis in HNC cells.
Conclusions:
- Ferroptosis-related hub genes, particularly COL4A1, are potential diagnostic and prognostic indicators for HNC.
- These genes represent promising therapeutic targets for enhancing HNC radiosensitivity and treatment outcomes.
Keywords:
alpha1 chaincollagen type IVferroptosishead and neck cancerradiotherapytumor microenvironmentMore Related Videos
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:12Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K